Sanofi Group (SNY) Cash on Hand per Share

Sanofi - graphic logo of issuer SNY

Sanofi (SNY) demonstrates the resilience of the defensive sector by focusing on immunological innovations. The company is implementing AI and automation to accelerate drug releases. Costly cold chain logistics ensure the integrity of complex vaccines. The amount of cash per share helps assess the intrinsic value of the stock, and 3.06 captures the magnitude of this parameter on this chart.

SNY (Sanofi Aventis) Cash per Share history from 07/04/2022 to 11/20/2026

Analytical breakdowns for Sanofi

- current price and projected stock value:
- market capitalization details:
- cash availability and cash flow indicators:
General company analysis:SNY (Sanofi Group)
Manufactured product of Sanofi SA

This indicator calculates the volume of liquid assets per share, allowing for an objective assessment of the business's financial stability and its protection against default. By analyzing the cash per security metric, an investor can see how the ultra-high margins from the sale of patented drugs by Sanofi (SNY) transform into real capital, ensuring a balance between security and growth rates.